FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 9 EU WC, 2 KDMF, 12 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

366 FDF Dossiers, 80 FDA Orange Book, 217 Europe, 3 Canada, 34 Australia, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Topical, 13 Film Formers & Plasticizers, 9 Parenteral, 8 Emulsifying Agents, 6 Solubilizers, 6 Thickeners and Stabilizers, 4 Taste Masking, 4 Lubricants & Glidants, 4 Fillers, Diluents & Binders, 4 Coating Systems & Additives, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

49 News #PharmaBuzz

49 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 16 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/02/2026	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN	R1-CEP 2012-079 - Rev 00	Betamethasone dipropionate, Micronised	2018-02-19	Valid	Chemical		809
27/02/2026	Symbiotica Speciality Ingredients Sdn Bhd	Malaysia	SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Butterworth MY	CEP 2011-005 - Rev 02	Betamethasone dipropionate	2024-12-23	Valid	Chemical		809

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene

Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

59 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

9 EU WC

2 KDMF

12 NDC API

37 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

366 FDF Dossiers

80 FDA Orange Book

217 Europe

3 Canada

34 Australia

9 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 Actylis

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Topical

13 Film Formers & Plasticizers

9 Parenteral

8 Emulsifying Agents

6 Solubilizers

6 Thickeners and Stabilizers

4 Taste Masking

4 Lubricants & Glidants

4 Fillers, Diluents & Binders

4 Coating Systems & Additives

3 Direct Compression

3 Surfactant & Foaming Agents

2 Granulation

2 Controlled & Modified Release

2 Chewable & Orodispersible Aids

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

49 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions

16 Regulatory FDF Prices

16 Annual Reports

MARKET PLACE

23 APIs

1 FDF Dossiers

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons